Voltaren Arthritis Pain Gel: How It Works and When To Use It

Voltaren Arthritis Pain Gel is a topical nonsteroidal anti-inflammatory drug (NSAID) designed to relieve joint pain from osteoarthritis by delivering diclofenac sodium through the skin directly to the affected area FDA, 03/01/2020.

As of: 05/31/2026 | Reading time: approx. 9 minutes

By the AD HOC NEWS editorial team - specialized in product-focused market coverage.

What Voltaren Arthritis Pain Gel Is and How It Works

Voltaren Arthritis Pain Gel is a medicated topical gel containing diclofenac sodium, an NSAID that helps relieve arthritis pain when applied to joints such as knees, hands, or feet FDA, 03/01/2020.

Unlike oral pain relievers, this gel is applied directly to the skin over the painful joint so that diclofenac can penetrate locally through the skin barrier and act in the underlying tissues where osteoarthritis pain originates FDA, 03/01/2020.

Diclofenac works by inhibiting cyclooxygenase enzymes that help produce prostaglandins, substances involved in pain and inflammation pathways in osteoarthritis-affected joints FDA, 03/01/2020.

Why Voltaren Arthritis Pain Gel Matters for US Consumers and Industry

For US adults living with osteoarthritis, Voltaren Arthritis Pain Gel offers an over-the-counter option so they can access diclofenac in a topical form without a prescription while staying within FDA-labeled directions FDA, 03/01/2020.

Topical NSAIDs can be useful when consumers and clinicians want to target arthritis pain locally at specific joints rather than relying solely on systemic NSAID tablets taken by mouth, particularly for adults focused on one or two problem areas FDA, 03/01/2020.

In US consumer healthcare, Voltaren Arthritis Pain Gel belongs to a broader shift toward self-managed pain relief products that are available in pharmacies, supermarkets, and online channels within FDA over-the-counter frameworks FDA, 03/01/2020.

Voltaren Arthritis Pain Gel in the US and Global Market

Voltaren-branded topical diclofenac products are part of a global portfolio of consumer pain relief medicines marketed in multiple countries, with local regulatory approvals guiding specific indications and formulations in each market FDA, 03/01/2020.

In the United States, Voltaren Arthritis Pain Gel is positioned for adults with osteoarthritis joint pain, complementing other OTC pain relief categories such as oral NSAIDs, acetaminophen, and non-medicated topical products within retail shelves.

Global consumer health companies market Voltaren-branded topical diclofenac alongside other everyday health brands, reflecting continued demand for nonprescription options that fit into daily pain management routines for adults.

• Topical gel format aimed at osteoarthritis joint pain relief in adults
• Uses diclofenac sodium, a nonsteroidal anti-inflammatory drug
• Applied directly to skin over affected joints, not taken orally
• Available without prescription for adults in the United States
• Part of a broader portfolio of consumer pain relief products

Voltaren as a brand is part of the consumer health portfolio historically associated with global consumer healthcare businesses, and more recently aligned with Haleon as a dedicated consumer health company.

Haleon, the company behind Voltaren Arthritis Pain Gel in many markets, is an independent consumer health group with securities identified under the ISIN GB0009252882 on international capital markets.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.